Fulcrum Therapeutics Inc (FULC)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
285,352,000
EV to revenue ratio (TTM)
117.4
EV to ebitda
-3.095
Financial Performance
Revenue (TTM)
0
Gross profit (TTM)
-56,103,000
EBITDA
-85,396,000
Profitability
Operating margin (TTM)
0.00%
Profit margin
0.00%
Return on assets (TTM)
-19.60%
Return on equity (TTM)
-32.40%
Per Share Metrics
Revenue per share (TTM)
0
EPS
-1.21
Diluted EPS (TTM)
-1.21
Book value
4.07
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
Trailing P/E
Forward P/E
PEG ratio
Price to sales ratio (TTM)
2.657
Price to book ratio (TTM)
0.936
Growth
Quarterly earnings growth (YoY)
-100.00%
Quarterly revenue growth (YoY)
0.00%
Analyst Sentiment
Strong buy
0
Buy
0
Hold
5
Sell
0
Strong sell
1
Risk & Volatility
Beta
2.585